| Schedule of Fair Value of the Shares and Warrants |
In accordance with IFRS 2, the Company has treated the difference between the net liability position and fair value of the shares and warrants of $67,797,276 as a listing expense. | | | 28 February
2024
$ | | | Fair value of equity instruments to have been issued by CRML | | | | | Sizzle share consideration price | | $ | 10.20 | | | Total number of Sizzle shares at closing | | | | | | Sponsor shares | | | 4,313,599 | | | Sizzle Public shares | | | 91,999 | | | | | | 4,313,599 | | | | | | | | | Total fair value of equity instruments issued to Sizzle shareholders | | | 43,998,710 | | | Fair value of identifiable net assets of Sizzle: | | | | | | Cash and cash equivalent | | | 9,835,289 | | | Proceeds from trust account attributable to not redeemed shares held by Empery | | | (8,819,744 | ) | | Accrued offering costs and expenses | | | (11,979,192 | ) | | Excise tax payable | | | (1,630,890 | ) | | Deferred underwriters fee | | | (8,150,000 | ) | | Income tax payable | | | (675,442 | ) | | Promissory note – related party | | | (1,459,437 | ) | | Listed warrants | | | (919,150 | ) | | Fair value of identifiable net assets of Sizzle at 29 February 2024 | | | (23,798,566 | ) | | | | | | | | IFRS 2 listing expense | | | 67,797,276 | |
|